- General info
- Available languages
- Background story
Saral™ Devanagari font family
Designed by Linotype Design Studio in 2007
Up to 3 Typefaces / 1 Value Packs
Available licenses for all styles:
Supports up to 50 languages.
Please select a format to view the available languages:
Supports up to 14 OpenType features.
Please select a format to view the available OpenType features:
Saral, meaning simple in Hindi, is a monolinear design supporting most Devanagari based languages. Derived from the older Linotype typeface Rohini, it has been greatly expanded into three weights and a wide character set. Saral Light, Regular, and Bold are made to coordinate with the respective weights of Helvetica. This design works well in many environments, such as corporate designs, advertising, packaging, signage, and especially for bi-lingual texts. The OpenType font format accommodates hundreds of pre-composed conjuncts, accurate placement of vowel signs, and supports varying length matras. Saral's Unicode encoding guarantees your text is rendered correctly and is compatible across different software and computer platforms.
Please note that due to current operating system and application limitations the OpenType features in complex scripts such as Davanagari are not universally supported. Saral is designed to be rendered correctly in Microsoft Word on Windows running the latest version of Uniscribe. If using a Mac or Adobe products such as InDesign then many features may not function as expected. This is including glyph reordering, substitutions, and mark positioning. In the case of small passages of text, alternate input methods can be employed. Apple's character palette and Adobe's glyph palettes are two readily available options that can be used to manually insert glyphs as needed."
Download a free trial
Use this font in your own documents with a free 5 minute trial through SkyFonts. Trials are for evaluation purposes only. Learn more.
This font is currently not available.
You already tried this font within the last 24 hours or you may have exceeded your daily allowance of trials. Learn more.